By Bhanvi Satija LONDON (Reuters) -German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 ...

"I began running again, and it helped me reclaim my independence and gave me back a sense of achievement that cancer ...

When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...

Lingen Davies Cancer Support has launched its biggest appeal to date – to deliver the Lingen Davies Cancer Centre at the ...

Europe's health regulator has recommended the approval of GSK's cancer treatment Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy, the ...

Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...

Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral ...

Beverly was 41, had two children and was contemplating a third when her first mammogram revealed a lump. Diagnosed with breast cancer, Beverly, who lives in Portland, Oregon, opted for chemotherapy, ...

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct. 13, ...

The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance treatment for a form of advanced ovarian cancer, ...